Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilaprazole Triple Therapy for H. pylori Eradication
NCT02873065Phase 4Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Sep 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ilaprazole in Helicobacter pylori infection, sponsored by Livzon Pharmaceutical Group Inc.. Started Sep 2014; status: completed.
02
Drugs
ilaprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02873065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02873065.